Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

Press releases published on April 28, 2026

Apr. 28, 2026

Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting

Indeterminate GlobeNewswire

Apr. 28, 2026

Axogen, Inc. Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 28, 2026

Manitoba Harvest Launches Superfood Smoothie Boosters, Exclusively at Sprouts Farmers Market Nationwide

Indeterminate GlobeNewswire

Apr. 28, 2026

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

Indeterminate GlobeNewswire

Apr. 28, 2026

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

Indeterminate GlobeNewswire

Apr. 28, 2026

Climb Bio, Inc. Announces $110.0 Million Private Placement

Indeterminate GlobeNewswire

Apr. 28, 2026

Burning Rock Publishes 2025 Annual Report on Form 20-F

Indeterminate GlobeNewswire

Apr. 28, 2026

Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead…

Indeterminate GlobeNewswire

Apr. 28, 2026

RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire

Apr. 28, 2026

The Ensign Group Schedules First Quarter 2026 Earnings Call for Friday, May 1, 2026

Indeterminate GlobeNewswire

Apr. 28, 2026

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Indeterminate GlobeNewswire

Apr. 28, 2026

Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial

Indeterminate GlobeNewswire

Apr. 28, 2026

KFSH Awards Innovation Challenge Winners at C3 Davos of Healthcare™ Silicon Valley Summit

Indeterminate GlobeNewswire

Apr. 28, 2026

Dr. Petros Kotsidis: KFSH Positions AI as a Scalable Model for Real-World Healthcare Innovation

Indeterminate GlobeNewswire

Apr. 28, 2026

Dr. Björn Zoëga: Scaling Integrated Digital Systems Will Define the Future of Healthcare

Indeterminate GlobeNewswire

Apr. 28, 2026

Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer

Indeterminate GlobeNewswire

Apr. 28, 2026

Reacta Healthcare Announces Expansion into Asia-Pacific and Appoints Professor Gary Wing-Kin Wong to Advisory Board

Indeterminate GlobeNewswire

Apr. 28, 2026

Castle Rock Hormone Health Announces National Franchise Launch with Franchise Sidekick Amid Growing Demand for Longevity Medicine

Indeterminate GlobeNewswire

Apr. 28, 2026

Bioxodes to present final Phase 2a trial results confirming breakthrough potential of BIOX-101 for intracerebral hemorrhage in poster at ESOC 2026

Indeterminate GlobeNewswire

Apr. 28, 2026

Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial

Indeterminate GlobeNewswire